Spanish drugmaker Grifols said Health Canada (Canada’s health regulator) suspended the license to collect plasma at its Taylor Avenue facility in Winnipeg, but operations would be unaffected because the company had already voluntarily halted collection there. The Globe and Mail reported that the regulator acted after raising concerns about the facility’s quality-management system following a donor’s death last year. Grifols said donor and patient safety, as well as plasma quality, had not been compromised at Taylor Avenue or its other Canadian centers. The company is working with Health Canada on a reopening plan and has reviewed operations across its centers, including staff retraining and improvements to procedures and quality systems. CBC News reported earlier this year that two people died in October 2025 and January 2026 after donating plasma at Grifols clinics in Winnipeg. Grifols also said it had taken full management control of Canada Plasma Inc. after governance arrangements had limited its ability to direct the business, accelerating its purchase of the remaining ownership stake after Health Canada identified deficiencies at several donation centers.